Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
NCT05003037
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
106
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG:
Surufatinib,Toripalimab,Pemetrexed,Carboplatin/Cisplatin
Sponsor
Li Zhang, MD